Login
$EBS
$5.75 -$0.04 (0.78%) Live

$EBS SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
04 Nov 2026 8-K: Other Events

Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War

03 Nov 2026 10-Q 9.30.26
02 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

GAITHERSBURG, Md., November 2, 2026—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2026.

16 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation

GAITHERSBURG, Md., October 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Richard S. Lindahl, executive vice president, chief financial officer, will retire from the Company effective December 31...

07 Oct 2026 144
07 Oct 2026 Form 4: DeGolyer Donald W, Director

Sold 17,800 shares ($126K)

05 Oct 2026 Form 4: Williams Paul Anthony, SVP, Products Business

Sold 3,000 shares ($19.6K)

01 Oct 2026 144
14 Sep 2026 8-K: Regulation FD Disclosure

1 September 14, 2026 Combating Public Health Threats for Communities Around the World Joe Papa President and Chief Executive Officer H.C. Wainwright 28th Annual Global Investment Conference

01 Sep 2026 8-K: Other Events

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

14 Aug 2026 SCHEDULE 13G
12 Aug 2026 Form 3: Duatschek Stephanie, EVP, CGO

Holds 197,416 shares of Common Stock

06 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +2 more

GAITHERSBURG, Md., August 5, 2026—Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2026.

31 Jul 2026 SCHEDULE 13G/A
28 Jul 2026 SCHEDULE 13G/A
02 Jul 2026 Form 4: Williams Paul Anthony, SVP, Products Business

Sold 3,000 shares ($25.2K)

01 Jul 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support